Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Strategy (STRF) Gains from Sales and Divestitures (2021 - 2025)

Strategy's Gains from Sales and Divestitures history spans 5 years, with the latest figure at $371000.0 for Q3 2025.

  • For Q3 2025, Gains from Sales and Divestitures changed N/A year-over-year to $371000.0; the TTM value through Sep 2025 reached $371000.0, changed N/A, while the annual FY2024 figure was $571000.0, 56.44% up from the prior year.
  • Gains from Sales and Divestitures for Q3 2025 was $371000.0 at Strategy, down from $571000.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $571000.0 in Q4 2024 and bottomed at $3927.0 in Q1 2022.
  • The 5-year median for Gains from Sales and Divestitures is $27000.0 (2021), against an average of $167192.7.
  • The largest annual shift saw Gains from Sales and Divestitures surged 1558.82% in 2022 before it rose 29.43% in 2023.
  • A 5-year view of Gains from Sales and Divestitures shows it stood at $17000.0 in 2021, then skyrocketed by 1558.82% to $282000.0 in 2022, then grew by 29.43% to $365000.0 in 2023, then soared by 56.44% to $571000.0 in 2024, then tumbled by 35.03% to $371000.0 in 2025.
  • Per Business Quant, the three most recent readings for STRF's Gains from Sales and Divestitures are $371000.0 (Q3 2025), $571000.0 (Q4 2024), and $37000.0 (Q2 2024).